Protein C News and Research

RSS

Study shows mRNA-based COVID vaccines enhance effectiveness of immune checkpoint therapy

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center.

22 Oct 2025

Scientists question the safety and efficacy of the diet for metabolic health

A study published in Science Advances by University of Utah Health researchers sheds light on the long-term effects of the ketogenic diet, raising important questions about its safety and efficacy for improving metabolic health.

22 Oct 2025

Discovery offers a breakthrough approach to combat prostate tumor growth

Prostate cancer relies on genetic "switches", called enhancers, that can turn on tumor-promoting genes.

22 Oct 2025

Researchers develop a novel approach to monitor CD8⁺ T cell activity over time

The ability of immune cells-particularly CD8+ T cells-to launch a rapid burst of proliferation inside tumors is key to the success of modern day cancer immunotherapies.

21 Oct 2025

New discovery could someday help prevent breast cancer recurrence

Know someone who's been diagnosed with breast cancer? There's a good chance that person has received hormone therapy.

21 Oct 2025

Using placental growth factor to predict preeclampsia risk in pregnant women with sickle cell disease

In pregnant women with sickle cell disease, the risk of developing early-onset preeclampsia can be determined by measuring levels of a protein associated with placental function and development.

21 Oct 2025

Genetic inflammatory signature defines depression subtypes and treatment response

Researchers led by Prof. Alessandro Serretti at Kore University of Enna have identified a genetic inflammatory signature that defines specific depression subtypes and influences how patients respond to antidepressant medications, according to new peer-reviewed research published today in Genomic Psychiatry.

21 Oct 2025

New AI-driven approach identifies treatments to reprogram and destroy cancer stem cells

Scientists at University of California San Diego have developed a new approach to destroying cancer stem cells – hard-to-find cells that help cancers spread, come back after treatment and resist therapy.

21 Oct 2025

Scientists uncover a key mechanism that protects the skin from harmful inflammation

Researchers at VIB and Ghent University have uncovered a key mechanism that protects the skin from harmful inflammation.

21 Oct 2025

Women with isolated REM sleep behavior disorder show lesser brain atrophy than men

A large international study involving nearly 700 participants reveals that women with a precursor condition to Parkinson's disease show significantly less brain atrophy—decreased cortical thickness in the brain—than men, despite similar clinical severity.

21 Oct 2025

Researchers develop a new approach for treating children with neuroblastoma

A research team from the University of Zurich and the University Children's Hospital Zurich has developed a new approach for treating children with malignant tumors of the nervous system.

21 Oct 2025

BMAC treatment accelerates healing for ACL, MCL, and meniscus tears

Bone marrow aspirate concentrate (BMAC) is a common treatment for joint injuries.

21 Oct 2025

Blood proteins reveal MS immune system attack starts years before symptoms

By the time patients start seeking care for multiple sclerosis (MS), the disease has already been damaging their brains for years. But until recently, scientists didn't understand which brain cells were being targeted or when the injury began.

21 Oct 2025

Largest trial of adjuvant pembrolizumab in Merkel cell carcinoma reports key benefit

A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body's immune system to target and eliminate cancer cells appeared to reduce the risk of distant metastases for an aggressive form of skin cancer when given immediately after surgery, but did not significantly reduce the overall risk of recurrence, which was a co-primary endpoint of the trial.

21 Oct 2025

New mechanism explains life-threatening pre-eclampsia at the molecular level

Pre-eclampsia is one of the most serious complications in pregnancy, affecting millions of women and newborns worldwide and potentially life-threatening. Despite intensive research, it has remained unclear what processes in the placenta lead to the disease.

21 Oct 2025

Gender-affirming hormone therapy rewrites body proteins to match gender identity

Melbourne researchers have discovered gender-affirming hormone therapy can alter body proteins to match a person's gender identity, potentially affecting susceptibility to certain health conditions.

21 Oct 2025

Researchers engineer a tool to dismantle cancer's RNA-built growth hubs

In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form-but instead of fueling progress, they supercharge disease. That's what researchers at the Texas A&M University Health Science Center (Texas A&M Health) have discovered inside the cells of a rare and aggressive kidney cancer.

21 Oct 2025

Study reveals protein plaques in neurodegeneration function as enzymes, breaking down ATP

A new study led by Rice University's Pernilla Wittung-Stafshede has revealed that protein clumps, or plaques that clog the brain, associated with Parkinson's disease are not merely waste; they can actively drain energy from brain cells.

21 Oct 2025

Why the first 1,000 days matter most in preventing childhood obesity

The EndObesity Consortium’s narrative review underscores that most childhood obesity risks emerge in the first 1,000 days, well before birth, highlighting gaps in parental, social, and policy interventions. Effective prevention demands preconception-focused, family-wide, and system-level strategies built on equitable public health frameworks.

20 Oct 2025

Heavy drinking fuels Alzheimer’s disease by igniting brain inflammation and protein damage

Chronic alcohol use accelerates Alzheimer’s disease (AD) progression by intensifying oxidative stress, neuroinflammation, and amyloid-tau pathology through shared molecular pathways. The review highlights emerging therapies, targeting TLR4, GSK-3β, and metabolic dysfunction, that may mitigate alcohol-induced neurodegeneration.

20 Oct 2025

Previous
1
...
26
27
28
29
30
31
32
...
2524
Next

Protein C News and Research

Study shows mRNA-based COVID vaccines enhance effectiveness of immune checkpoint therapy

Scientists question the safety and efficacy of the diet for metabolic health

Discovery offers a breakthrough approach to combat prostate tumor growth

Researchers develop a novel approach to monitor CD8⁺ T cell activity over time

New discovery could someday help prevent breast cancer recurrence

Using placental growth factor to predict preeclampsia risk in pregnant women with sickle cell disease

Genetic inflammatory signature defines depression subtypes and treatment response

New AI-driven approach identifies treatments to reprogram and destroy cancer stem cells

Scientists uncover a key mechanism that protects the skin from harmful inflammation

Women with isolated REM sleep behavior disorder show lesser brain atrophy than men

Researchers develop a new approach for treating children with neuroblastoma

BMAC treatment accelerates healing for ACL, MCL, and meniscus tears

Blood proteins reveal MS immune system attack starts years before symptoms

Largest trial of adjuvant pembrolizumab in Merkel cell carcinoma reports key benefit

New mechanism explains life-threatening pre-eclampsia at the molecular level

Gender-affirming hormone therapy rewrites body proteins to match gender identity

Researchers engineer a tool to dismantle cancer's RNA-built growth hubs

Study reveals protein plaques in neurodegeneration function as enzymes, breaking down ATP

Why the first 1,000 days matter most in preventing childhood obesity

Heavy drinking fuels Alzheimer’s disease by igniting brain inflammation and protein damage

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News